Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.
about
Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy DeliveryHyaluronan, Inflammation, and Breast Cancer ProgressionThe roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progressionHuman serum-derived protein removes the need for coating in defined human pluripotent stem cell culture.Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer.Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancerImproving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expressionHyaluronan synthase 2 protects skin fibroblasts against apoptosis induced by environmental stress.Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosisInhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.Molecular characterization of kidney cancer: association of hyaluronic acid family with histological subtypes and metastasis.Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo.Modulation of extracellular matrix in cancer is associated with enhanced tumor cell targeting by bacteriophage vectorsInhibition of hyaluronan synthase-3 decreases subcutaneous colon cancer growth by increasing apoptosisIdentification, design and synthesis of tubulin-derived peptides as novel hyaluronan mimetic ligands for the receptor for hyaluronan-mediated motility (RHAMM/HMMR).Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions.Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer.Dietary flavonoid fisetin increases abundance of high-molecular-mass hyaluronan conferring resistance to prostate oncogenesis.Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cellsCD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).Antitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancerHyaluronic acid synthesis is required for zebrafish tail fin regeneration.C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancer.The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activityThe hyaluronan synthesis inhibitor 4-methylumbelliferone exhibits antitumor effects against mesenchymal-like canine mammary tumor cells.Tumor Microenvironment Remodeling by 4-Methylumbelliferone Boosts the Antitumor Effect of Combined Immunotherapy in Murine Colorectal Carcinoma.The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine CarcinomaSynthesis of N-acetyl Glucosamine Analogs as Inhibitors for Hyaluronan Biosynthesis.Over expression of hyaluronan promotes progression of HCC via CD44-mediated pyruvate kinase M2 nuclear translocation.4-Methylumbelliferone Diminishes Catabolically Activated Articular Chondrocytes and Cartilage Explants via a Mechanism Independent of Hyaluronan Inhibition.Anti-tumor and anti-invasion effects of a combination of 4-methylumbelliferone and ionizing radiation in human fibrosarcoma cells.4-Methylumbelliferone Suppresses Hyaluronan Synthesis and Tumor Progression in SCID Mice Intra-abdominally Inoculated With Pancreatic Cancer Cells.The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma.Targeting hyaluronic acid family for cancer chemoprevention and therapy.Sugars in the microenvironment: the sticky problem of HA turnover in tumors.Relation between hyaluronan synthesis and cell morphology in ovarian clear cell carcinomas.The Role of CD44 in Disease Pathophysiology and Targeted Treatment.Glycosaminoglycans and glucose prevent apoptosis in 4-methylumbelliferone-treated human aortic smooth muscle cells
P2860
Q26786070-2550A5F1-D534-49E3-B919-BDC66428C719Q27006607-CAFEAA37-F12E-4A4C-BE8C-65B0FA00C168Q27025313-6E7BE7A4-E737-4A0F-A32C-7CECCEF95C9FQ27335859-9504F1B7-4902-47E8-B0B0-46ED34F68F4EQ33648449-D50D7B03-ACEF-40AC-A663-3E6F95399CBFQ33855839-BA52A3F6-F66B-48CF-B3C4-2DDB077C711AQ34145464-7184F10E-6FF3-403F-914E-E5B0F1EC4EFEQ34346660-F7186AA5-8F92-40E3-8BF3-0D21E7A6F8A5Q34509837-0A23DC48-661E-40C0-8C12-D3B94585F27CQ34512129-C327DD6C-981B-4E8D-B55E-D1E15E7CB8C4Q34809359-2699193D-DD03-4A05-9A4F-69E4D1585F87Q35206080-C836486E-8FE7-4642-881F-254E0952AF14Q35597200-9D467961-6A3D-4C0F-B78B-AEB31D5396C4Q35653938-007BEAD2-4046-4128-83B5-4B7FD2693779Q35672938-83B3366E-70B4-4BF9-B49D-7B058B246E08Q35693859-F2C72964-2DC6-4DA0-8349-CB75E492CB3CQ35802940-2AB6E21A-EFF3-49EA-AF35-171DA9067B0AQ35971408-E083D6F6-6B7B-4F47-B6F6-E4E4A63CB8B6Q36009814-B76E816B-4E83-46E0-99AF-CF307E296E14Q36059412-33E3F744-ECCF-44AA-A797-0BA2613B77E2Q36116059-D6DF8888-9199-44E6-A42A-994B70FB39D6Q36123305-4233A4AC-7DC8-4D7B-8EAD-F8DDAEF3FE6AQ36152259-B16A6A39-2ADA-4220-9BC8-E3017C1CF551Q36282597-12831C5E-19CD-4897-A222-53D5A0C012F9Q36287809-134ACC48-3A5D-4F15-A178-29E9680F8B13Q36404904-0B4D58C7-5E56-4955-9C11-1DB7D931E22BQ36621561-49A10ABB-EA1C-48D6-B37C-E169978E1FDAQ36757056-EA6FFB08-9B91-477F-93C4-77604CDED273Q36805567-CBBAA127-AF07-4DE4-A6C7-20939E692C9CQ36807807-33B73F32-FFF3-4069-9F55-0611DE590A33Q36878785-94DBCF30-D9B6-406C-B702-4CFB93C5EF09Q37065986-865A06D4-03EE-4FDE-BBAF-59FC547B1EEDQ37594092-7990C70B-9AFA-450B-B22C-E21206765EE7Q37606733-093732BB-3C15-42D9-8F99-C20F57AB7D21Q37729238-AE92963B-4F53-4455-9A87-DB22071D8C2CQ38235792-784CCEC0-616F-47CD-BB21-FC6FF6159A2DQ38260975-11C0FE65-1F2B-4109-8ABB-4688358122FCQ38381443-BA29D71B-B639-4479-BAAC-655D4805168FQ38466771-3DAB0E55-C2CA-4BC5-B7AE-EBC6699096B3Q38621433-3E658F3F-FADF-4DEB-97A7-1196089AEAA5
P2860
Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Antitumor activity of hyaluron ...... rone in prostate cancer cells.
@en
Antitumor activity of hyaluron ...... rone in prostate cancer cells.
@nl
type
label
Antitumor activity of hyaluron ...... rone in prostate cancer cells.
@en
Antitumor activity of hyaluron ...... rone in prostate cancer cells.
@nl
prefLabel
Antitumor activity of hyaluron ...... rone in prostate cancer cells.
@en
Antitumor activity of hyaluron ...... rone in prostate cancer cells.
@nl
P2093
P2860
P1433
P1476
Antitumor activity of hyaluron ...... rone in prostate cancer cells.
@en
P2093
Andrew Chi
Daniel Munoz
Diogo O Escudero
Luis E Lopez
Neetika Dhir
Norman Altman
Samir P Shirodkar
Soum D Lokeshwar
Vinata B Lokeshwar
P2860
P304
P356
10.1158/0008-5472.CAN-09-3185
P407
P577
2010-03-23T00:00:00Z